As a non- ionic contrast medium, ioversol featuring low toxicity and few effects is mainly used to enhance the contrast of blood vessels in medical imaging. Containing iodine, ioversol works based on x- ray attenuation.
Contrast medium is commonly used to enhance the visibility of blood vessels and body cavity. And its application area has expanded from X- ray/CT imaging to ultrasound scattering and magnetic resonance imaging. In recent years, contrast agent market in China has maintained a growth of about 20%. Ioersol, in particular, has reported a growth of 60%. Currently, ioersol is used in many hospitals due to its cheap price and good quality.
Ioversol enjoys a vast demand with sales value of ioversol rising from less than CNY 30 million in 2005 to over CNY 200 million in 2014 and CAGR during this period reaching 27%. Mallinckrodt Medical Inc.(Canada), Mallinckrodt Medical Inc.(USA) and Jiangsu Hengrui Medicine Co., Ltd mainly occupy the market, among which Jiangsu Hengrui Medicine Co., Ltd had the largest market share of over 80% for sales value in 2014.
Readers can get the following information through this report:
Market size of ioversol in China
Competitive landscape of ioversol market in China
Price of ioversol made by different enterprises in China
Market outlook of ioversol in China
The author suggests the following groups of people purchase this report:
Drug makers
Investors/research institutions interested in Chinese medicine market
Key topics covered in report
China Ioversol Market Sales
China Ioversol Market Share
China Ioversol Market Players
China Ioversol Market Outlook
China Ioversol Market Size
China Ioversol Market Forecast
China Ioversol Market Research Report
China Ioversol market Anlaysis
For More Coverage Click On the Link Below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249
No comments:
Post a Comment